Ethics and transparency
navigate_next Compliance navigate_next
Savio Pharma Italia in the awareness that it contributes to the formation of an increasingly modern healthcare, to the benefit of citizens' health, inspires its behavior with principles of ethicality and transparency.
Relationship with stakeholders
Savio Pharma Italia believes it is necessary to establish an ethical, loyal and transparent relationship with its interlocutors: be they Health Care Professionals, Institutions, Citizens, Collaborators, Business Partners.
On this basis, the Company operates in accordance with current rules and regulations, professional ethics and internal policies. Although not associated with Farmindustria, Savio Pharma Italia observes the Code of Ethics issued by this association.
Moreover, on the basis of the ethical principles that guide its actions and in order to meet the increasingly pressing and continuous expectations of legality and transparency manifested by both Citizens and Institutions, Savio Pharma italia has adhered with conviction to the EFPIA Code (European Federation of Pharmaceutical Associations and Industries) whose contents have been incorporated into Farmindustria’s Code of Ethics.
The correct and positive relationship established between the pharmaceutical industry and healthcare professionals (HCP: Healthcare Professionals) and/or healthcare organizations (HCO: Healthcare Organisations) has always led to the research and development of innovative therapies, useful for safeguarding one of the rights fundamentals of Citizens and constitutionally guaranteed, i.e. the right to health. In fact, it is worth highlighting that the Transfers of Value between the pharmaceutical industry and the medical community, to which the EFPIA Code refers, cannot and must not be considered exclusively as transfers of an economic nature; they also allow the mutual transfer of a much more important value which is that of scientific knowledge, to the full advantage of Citizens/Patients.
he cooperation between pharmaceutical Industry, healthcare Operators and healthcare Organisations, already well regulated by the current legislation, becomes even more transparent thanks to the application of the EFPIA Code.
Such further transparency in relationships shall consolidate the basis for the future collaborations and lead to further benefits for Citizens/Patients that, having the opportunity to know the contents of such relationships, shall be in the condition to receive the proposed treatments with greater trust and awareness.
Transfers of Value
The Transfers of Value, which data publication is requested for, are those relative to the participation to Events (Conventions, Congresses, Visits to production plants…), consulting and professional services, donations and contributions, research and development (clinical, non-clinical and prospective observational studies).
Code of Conduct and MOMC ex Legislative Decree n. 231/2001
The pursuit of the Company’s interests can never justify conduct contrary to the principles of honesty, correctness, legitimacy and transparency. To this end, the Company’s Administrative Body has adopted the Code of Conduct which, in addition to identifying the reference ethical standards, highlights the set of rights, duties and responsibilities of all those who, in any capacity, operate therein , whether they are employees, consultants or in any case subjects linked by a collaborative relationship. The Code of Conduct plays a key role in maintaining these principles: Savio Pharma Italia S.r.l. is committed to disseminating its contents to those who come into contact with it and requires compliance with this Code by its employees, ISFs, consultants and/or collaborators. The Code of Conduct also constitutes a governance tool and is an integral part of the company’s “Organization, Management and Control Model” for the protection from offenses as provided for in the Legislative Decree. n. 231/2001 regarding the administrative responsibility of the Company.